You might have heard the news already. The FDA approved Biogen's drug Aduhelm (aducanumab). Everyone seems to be celebrating. See @jimcaster 's post :
healthunlocked.com/cure-par...
Not so fast, says this opinion piece from a Bloomberg writer:
bloomberg.com/opinion/artic...
RKM
good article. Lays it all out.
Why I am not joyous about this announcement:
- at $56,000 per year / person, it will likely take money from other parts of health care;
- it signals an acceptance of post-hoc analysis: if a trial gives the wrong answer, collect more data, and try again
" if a trial gives the wrong answer, collect more data, and try again."
don't tell the believers and those who own Biogen stock about "post-hoc analysis" problems...(i.e. after the fact manipulation of the data).
Early-stage drug could stop Parkinson's disease in its tracks
Biogen has discontinued development of BIIB054
New Nrf2 activator drug gets FDA approval for Freidrich ataxiaTomato crop enriched with Parkinson's disease drug created
Parkinson's disease drug ropinirole safely slows the progression of amyotrophic lateral sclerosis
